They have approved products already. They have Phase 2 trials that demonstrate efficacy. They have major investments from sophisticated investors. I take from your comment you think the Phase 3 trials, and the Covid-19 trial will fail? If so, on what basis?
They have approved products already. They have Phase 2 trials...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.000(0.00%) |
Mkt cap ! $1.478B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.28 | $600.5K | 465.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 114353 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 5159 | 3 |
View Market Depth
| Last trade - 11.25am 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |